ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is delivering ...

Icon PLC (ICLR) delivered earnings and revenue surprises of 3.57% and 0.58%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024.On ...

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, announced today that it will present at the William Blair 45th ...